See Nurami Medical’s team at the 2022 CNS Annual Meeting in San-Francisco

Nurami Medical, which is developing a biodegradable surgical patch for Dura repair in neurosurgeries, has achieved its key endpoint in its clinical

Let’s meet at CNS 2022. Contact us to set up a meeting.

Nurami presented its novel technology at its booth and in a presentation given by Nurami COO, Dr. Amir Bahar.

As it near commercialization, Noam Sorek, a seasoned BD executive, with experience in launching medical device sales in international markets, joins Nurami.

Entrepreneurial MedTech leader, Peter Stebbins joins Nurami’s team

Nurami Medical has recruited all the patients for a clinical trial on its product, ArtiFascia, a synthetic implant for restoring and repairing

Nurami Medical has recruited all the patients for a clinical trial on its product to repair soft tissue damaged during neurosurgery

Nurami Medical, a medical device R&D company, which is developing a groundbreaking technology that facilitates post-surgical healing of soft tissue healing,

Nurami Medical develops innovative sealants and surgical patches based on unique combinations of advanced bioactive materials and optimized, electrospun nanofiber scaffolds